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tional PRNT results from 26 sera, of which 18 (69%) were 
positive, yields a 3.9% positivity rate. 
In addition to our study, with crude seroprevalence rates 
ranging from 3.9% to 10.1%, another recent study demon-
strated JCV antibodies in 2.9% to 13.3% of ill persons in 
Massachusetts (Tonry J et al., unpub. data). Although the 
screening results of our first serosurvey (10.1% positive) dif-
fered widely from those of the second serosurvey (3.9% posi-
tive), even the lower rate indicates substantial levels of 
human infection in Connecticut.
This report suggests that JCV infection is fairly fre-
quent in Connecticut and that illness may occur, as corrobo-
rated by data from neighboring Massachusetts (Tonry J et 
al., unpub. data) and unpublished laboratory findings from 
the Connecticut State Public Health Laboratory. The inter-
est in arboviral disease will continue unabated, spurred by 
the continued occurrence of WNV, and systematic testing for 
JCV infection may be timely, at least throughout the north-
eastern United States.
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A Newly Discovered Variant of a Hantavirus in 
Apodemus peninsulae, Far Eastern Russia
To the Editor: Hemorrhagic fever with renal syndrome 
(HFRS) is caused by Hantaan virus (HTNV) or Seoul virus 
(SEO) in Asia and Puumala virus (PUUV) or Dobrava virus 
(DOBV) in Europe (1). Each of these hantaviruses is predom-
inantly associated with a single rodent species as its primary 
natural reservoir: HTNV with the striped field mouse Apode-
mus agrarius, SEO with Rattus norvegicus, PUUV with the 
bank vole Clethrionomys glareolus, and DOBV with the yel-
low-necked mouse Apodemus flavicollis. An additional 
rodent reservoir of DOBV, A. agrarius, was reported recently 
(2). 
The first HFRS cases (then called “hemorrhagic neph-
roso-nephritis”) were clinically described in the Amur River 
basin during the 1920s by Russian scientists (3). Serologic 
studies suggest that numerous hantaviruses are present in 
humans and rodents in the far east of Asian Russia (4-5). 
Serologic evidence of hantavirus infection in A. agrarius, A. 
peninsulae (Korean field mouse), R. norvegicus, Cl. rufoca-
nus, Cl. rutilus, and Microtus fortis has been reported (5). 
Only Khabarovsk virus (KBR), isolated from M. fortis, has 
been characterized in detail, and no association with human 
disease was established (6). 
To genetically characterize hantaviruses in A. peninsu-
lae, we studied samples from rodents captured in July and 
August 1998 in the same region of the forest near Kha-
barovsk. Lung-tissue samples were screened by enzyme-
linked immunosorbent assay for HTNV/SEO/PUUV-related 
antigen. Samples from four hantavirus-positive rodents were 
tested by reverse transcription and nested polymerase chain 
reaction (PCR). Four M-segment PCR products (nt 2639-
3000) and two S-segment PCR products (nt 592-945) were 
produced and directly sequenced (GenBank accession num-
bers AF332569-AF332573). All sequences were closely 
related to each other, with nucleotide diversity between 
strains not exceeding 0.6% for M segments and 1.3% for S 
segments. Comparative analysis of the M segments showed 
that hantaviral nucleotide sequences from A. peninsulae  
were very similar to those we identified earlier in HFRS 
patients (diverging 3.1% to 6.6%), which we term the Amur 
genotype of HTNV (7). The S-segment sequences of the AMR 
genotype from human patients were not available for com-
parison. The nucleotide sequence (the M and S segments, 
respectively) of the hantavirus detected in A. peninsulae 
diverged substantially from those of other hantaviruses (15% 
and 19% for HTNV, 21% to 28% for SEO, 22% and 29% for 
DOBV, 38% and 39% for PUUV, and 36% and 37% for KBR). 
Neighbor-joining phylogenetic analysis based on partial 
sequences of the S segment indicated that the hantaviral 
sequences from A. peninsulae form a separate lineage on the 
phylogenetic tree, and together with HTNV virus strain 76-
118, which originates from A. agrarius, constitute a well-
supported group. A phylogenetic tree based on partial M seg-
ment sequences placed all hantavirus strains originating 
from A. peninsulae  or from HFRS patients apart from all 
HTNV sequences recovered from A. agrarius (strain 76-118) 
and HFRS patients from Korea (strains HoJo, Lee). The tax-
onomic placement of this hantavirus (Amur genotype) as a 
distinct hantavirus or a distinct genetic lineage of HTNV 
remains to be determined. In addition, the finding of distinct 
DOBV genetic lineages in A. flavicollis and A. agrarius 
raises the same question of whether the two DOBV variants 
represent distinct hantaviruses (2). 
A. peninsulae is widely distributed throughout eastern 
Asia, from Altai and south Siberia to the Russian far east, 
northeastern and eastern parts of China, and Korea. A sur-
vey of hantavirus antigens in rodent populations in the far 
east of Russia demonstrated the presence of HTNV-like anti-
gen in 8% to 16% of A. peninsulae (5). Whether pathogenic 
AMR genotype of virus exists in A. peninsulae throughout 
far eastern Asia, from Russia to China and Korea, requires 
further study. Comparing hantaviral genome sequences 
available from GenBank shows that the M segment nucle-
otide sequence recovered from an HFRS patient from China 
(strain H8205, GenBank accession number AB030232) was 
very similar to the AMR genotype from A. peninsulae (94% to 
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96% identity), suggesting that this hantavirus is also 
present in A. peninsulae in China. 
In earlier studies, we found that sera from patients 
infected by the AMR genotype of hantavirus showed exten-
sive cross-reactivity with HTNV and SEO antigens in immu-
nofluorescent antibody tests (7). Consequently, many HFRS 
cases previously thought to have been caused by HTNV or 
SEO may instead have been caused by infection with the 
hantavirus described here. 
Our data represent the first genetic evidence for the 
AMR genotype of HTNV in A. peninsulae and suggest that 
this rodent species may be a natural reservoir for this patho-
genic hantavirus.
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The editors of Emerging Infectious Diseases seek to
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International Conference on
Emerging Infectious Diseases, 2002
The National Center for Infectious Diseases,
Centers for Disease Control and Prevention, has
scheduled the third International Conference on
Emerging Infectious Diseases (ICEID2002) for
March 24-27, 2002, at the Hyatt Regency Hotel,
Atlanta, Georgia, USA. More than 2,500 partici-
pants are expected, representing many nations and
disciplines. They will discuss the latest information
on many aspects of new and reemerging pathogens,
such as West Nile virus and issues concerning bio-
terrorism.
Conferrence information is available
at http://www.cdc.gov/iceid
 The Call for Abstracts is available
at http://www.asmusa.org/mtgscr/iceido2.htm
Contact person is Charles Schable, cas1@cdc.gov
